Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bonheiden
Clinical trial register · Belgium

Clinical Trials in Bonheiden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Belgium and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3055 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
3055
Studies in scope
all four open statuses
1723
Recruiting now
open to new participants
505
Lead sponsors
across recruiting studies
Top sites
Leuven 1275 Brussels 1118 Ghent 1030 Liège 562 Edegem 441
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Universitaire Ziekenhuizen KU Leuven9 Eli Lilly and Company8 AbbVie8 Janssen Research & Development, LLC3 Bristol-Myers Squibb3 KANDO Research3 Novo Nordisk A/S3 Alfasigma S.p.A.2 Imelda Hospital, Bonheiden2 GlaxoSmithKline2 BioNTech SE2 Imelda GI Clinical Research Center2 Novartis Pharmaceuticals2 AstraZeneca2 Alimentiv Inc.2 iVascular S.L.U.2 Jazz Pharmaceuticals2 TripleMed B.V.1 St. Antonius Hospital1 Amgen1 Universitair Ziekenhuis Brussel1 Diagram B.V.1 Astellas Pharma Global Development, Inc.1 Sandoz1 Eisai Inc.1 Show all 61
Site location
Leuven1275 Brussels1118 Ghent1030 Liège562 Edegem441 Antwerp290 Bruges263 Roeselare249 Hasselt215 Aalst185 Kortrijk183 Charleroi175 Genk174 Anderlecht167 Yvoir153 Namur138 Jette128 Sint-Niklaas116 Bonheiden101 Wilrijk75 Brasschaat72 Mechelen61 La Louvière59 Woluwe-Saint-Lambert57 Ottignies48 Show all 205
All 205 locations
Target enrolment
to

Trials with a site in Bonheiden

101 of 3055 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Belgium
Start
Not yet open
Novo Nordisk A/S
Phase 3
1,408
Alken, Bonheiden, Genk, Ghent, Leuven, Mons
2026-11-11
Recruiting
Universitaire Ziekenhuizen KU Leuven
Observational
280
Anderlecht, Bonheiden, Bruges, Edegem, Leuven
2026-10-15
Recruiting
Solstice Oncology, Inc.
Phase 2
100
Anderlecht, Bonheiden, Ghent, Leuven, Liège, Ostend, Woluwe-Saint-Lambert
2026-09-30
Recruiting
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
NCT07405671Atrial Fibrillation (AF), Coronary Artery Disease
DrugsFlecainide·Amiodarone
Universitaire Ziekenhuizen KU Leuven
Phase 4
988
Aalst, Bonheiden, Bruges, Edegem, Genk, Ghent, Herentals, Ieper
2026-09
Recruiting
Novo Nordisk A/S
Phase 3
450
Alken, Bonheiden, Brussels, Ghent, Kluisbergen
2026-08-12
Recruiting
Flen Health
Not applicable
64
Bonheiden, Mechelen, Ghent, Charleroi, Liège, Arlon, Leuven, Bruges
2026-08-10
Recruiting
KANDO Research
Not applicable
200
Aalst, Bonheiden, Dendermonde, Genk
2026-07-01
Not yet open
Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon
NCT07650578Coronary Arterial Disease (CAD), Calcific Coronary Arteriosclerosis
University of Mons
Not applicable
200
Mons, Bonheiden, Brussels, Libramont, Liège, Lodelinsart
2026-07
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Bonheiden, Brugge (Bruges), Brussel (Bruxelles), Gent (Ghent), Koekelberg/Brussel (Bruxelles), Leuven, Liège
2026-05-23
Recruiting
AbbVie
Phase 3
990
Bonheiden, Edegem, Anderlecht, Brussels, Jette, Charleroi, Yvoir, Ghent
2026-05-22
Recruiting
Imelda GI Clinical Research Center
Observational
100
Bonheiden
2026-05-01
Recruiting
AbbVie
Observational
120
Bonheiden, Edegem, La Louvière, Tournai, Hasselt, Ghent, Leuven, Bruges
2026-03-09
Recruiting
iVascular S.L.U.
Not applicable
165
Bonheiden, Genk, Ghent, Gilly, Hasselt, Liège
2026-02-16
Recruiting
Eli Lilly and Company
Phase 3
900
Bonheiden, Brussels, Genk, Ieper, Kortrijk, Leuven, Mechelen, Ostend
2026-02-10
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Bonheiden, Edegem, Brussels, Charleroi, Leuven, Roeselare
2025-12-31
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bonheiden, Brasschaat, Brussels, Genk, Hasselt, Ieper, Kluisbergen, Kortrijk
2025-12-01
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Leuven, Roeselare, Bonheiden, Brussels
2025-11-11
Recruiting
BioNTech SE
Phase 3
558
Bonheiden, Brussels, Gilly, Leuven, Woluwe-Saint-Lambert
2025-10-30
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Bonheiden, Edegem, Anderlecht, Brussels, Ghent, Leuven, Liège
2025-10-23
Recruiting
The Belgian Society of Medical Oncology
Observational
550
Anderlecht, Antwerp, Bonheiden, Brasschaat, Edegem, Ghent, Gilly, Hasselt
2025-10-22
Not yet open
Multiple Digital Biomarkers for Optimization of IBD Care
NCT07159776Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD)
Imelda GI Clinical Research Center
Observational
80
Bonheiden
2025-09-08
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Aalst, Bonheiden, Brasschaat, Bruges, Brussels, Dendermonde, Erpent, Genk
2025-09-06
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Aalst, Alken, Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem
2025-09-02
Active, closed
Amgen
Phase 3
12,800
Aalst, Bonheiden, Bruges, Brussels, Edegem, Genk, Ghent, La Louvière
2025-07-25
Recruiting
Boehringer Ingelheim
Phase 3
11,800
Aalst, Alken, Bonheiden, Brussels, Edegem, Genk, Gozée, Hasselt
2025-07-22
Recruiting
GlaxoSmithKline
Phase 1/2
346
Bonheiden, Brussels, Leuven, Roeselare
2025-06-11
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bonheiden, Brussels, Edegem, Ghent, Leuven, Liège
2025-05-22
Recruiting
Universitaire Ziekenhuizen KU Leuven
Observational
30
Bonheiden, Bruges, Ghent, Hasselt, Leuven
2025-03-31
Recruiting
GlaxoSmithKline
Phase 2
120
Aalst, Bonheiden, Brussels, Ghent, Leuven, Liège, Ostend, Roeselare
2025-02-18
Recruiting
Alimentiv Inc.
Not applicable
378
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Edegem, Ghent, Leuven
2025-02-01
Recruiting
Takeda
Phase 3
396
Brussels, Bonheiden, Ghent, Leuven, Liège
2025-01-02
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Anderlecht, Bonheiden, Kortrijk
2024-12-13
Recruiting
Study on the Clinical Efficacy of Teclistamab and Talquetamab
NCT06477783Multiple Myeloma, Hematologic Diseases
DrugTeclistamab
Universitaire Ziekenhuizen KU Leuven
Observational
100
Bonheiden, Edegem, Charleroi, Hornu, Mons, Hasselt, Liège, Yvoir
2024-12-01
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
386
Aalst, Antwerp, Bonheiden, Bruges, Brussels, Ghent, Kortrijk, Leuven
2024-11-18
By invitation
Universitaire Ziekenhuizen KU Leuven
Observational
192
Bonheiden, Leuven, Roeselare
2024-10-14
Recruiting
AbbVie
Observational
280
Bonheiden, Anderlecht, Lodelinsart, Tournai, Liège, Genk, Ghent, Sint-Niklaas
2024-09-27
Recruiting
AbbVie
Phase 2
590
Bonheiden, Anderlecht, Brussels, Liège, Yvoir, Leuven, Kortrijk, Ostend
2024-09-04
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
Sint-Niklaas, Bonheiden, Ghent, Leuven, Roeselare, Brussels
2024-08-07
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Bonheiden, Edegem, Leuven
2024-07-19
By invitation
General Hospital Groeninge
Not applicable
339
Brasschaat, Edegem, Ghent, Leuven, Kortrijk, Bonheiden, Hasselt, Jette
2024-07-03
Active, closed
Eli Lilly and Company
Phase 3
10,000
Aalst, Alken, Bonheiden, Brasschaat, Brussels, Edegem, Ghent, Hasselt
2024-04-30
Recruiting
CSL Behring
Phase 2/3
3,110
Aalst, Bonheiden, Charleroi, Ghent, La Louvière, Leper, Leuven, Liège
2024-04-27
Recruiting
Universitaire Ziekenhuizen KU Leuven
Not applicable
90
Bonheiden, Bruges, Ghent, Hasselt, Leuven
2024-04-22
Recruiting
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
NCT06113913Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis
DrugInfliximab
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
Phase 4
275
Ghent, Ostend, Antwerp, Bonheiden, Bruges, Brussels, Genk, Leuven
2024-04-09
Active, closed
AstraZeneca
Phase 3
2,554
Aalst, Bonheiden, Brussels, Ghent, Ieper, Kortrijk, Leuven, Liège
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Bonheiden, Kortrijk, Sint-Niklaas
2024-03-27
Active, closed
Eli Lilly and Company
Phase 3
17,300
Antwerp, Bonheiden, Brasschaat, Brussels, Charleroi, Dendermonde, Edegem, Genk
2024-03-05
Recruiting
AZ Sint-Jan AV
Phase 3
2,770
Aalst, Antwerp, Bonheiden, Bruges, Charleroi, Genk, Ghent, Hasselt
2024-01-29
Recruiting
Anovo Surgical System in Ventral Hernia
NCT06457971Ventral Hernia
Momentis Surgical
Not applicable
50
Bonheiden
2024-01-14
Recruiting
Observational Study Protocol: LIVER-R
NCT06252753Hepatobiliary Cancers
AstraZeneca
Observational
4,000
Brussels, Bonheiden, Edegem, Leuven, Liège, Stene
2023-12-20
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Bonheiden, Aalst, La Louvière, Ronse, Bruges, Roeselare, Brussels, Liège
2023-11-30
Active, closed
AbbVie
Phase 2
280
Bonheiden, Edegem, Brussels, Ghent, Leuven, Roeselare, Anderlecht
2023-11-12
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Aalst, Auderghem, Bonheiden, Brasschaat, Bruges, Brussels, Haine-Saint-Paul, Hasselt
2023-10-24
Active, closed
iVascular S.L.U.
Phase 3
2,312
Bonheiden, Charleroi, Genk, Liège, Mons, Roeselare, Turnhout
2023-10-13
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Bonheiden, Ghent, Roeselare, Liège, Lodelinsart, Woluwe-Saint-Lambert
2023-07-06
Active, closed
Alfasigma S.p.A.
Observational
509
Bonheiden, Brussels, Edegem, Ghent, Heusden-Zolder, Leuven, Liège, Ostend
2023-06-12
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Bonheiden, Charleroi, Genk, La Louvière, Leuven, Liège, Namur, Yvoir
2023-04-25
Active, closed
AbbVie
Phase 3
520
Bonheiden, Brussels, Charleroi, Ghent, Leuven, Roeselare, Namur
2023-03-15
Active, closed
Sandoz
Observational
562
Aalst, Antwerp, Bonheiden, Brussels, Eeklo, Ghent, Herentals, Kortrijk
2023-02-16
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Antwerp, Ath, Bonheiden, Brussels, Dendermonde, Edegem, Kortrijk, La Louvière
2023-02-15
Recruiting
Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery
NCT05084339Bariatric Surgery Status Complicating Pregnancy
Universitaire Ziekenhuizen KU Leuven
Observational
190
Aalst, Antwerp, Bonheiden, Bruges, Ghent, Kortrijk, Leuven
2023-01-25
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
NCT04436978Acute Coronary Syndrome, Myocardial Infarction, Atrial Fibrillation, Atrial Flutter
St. Antonius Hospital
Phase 4
2,000
Aalst, Antwerp, Bonheiden, Brussels, Genk, Ghent, Ieper, Kortrijk
2023-01-11
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Bonheiden, Boussu, Brussels, Edegem, Ghent, Leuven, Mons
2022-11-01
Active, closed
Eli Lilly and Company
Phase 3
15,374
Aalst, Bonheiden, Brussels, Edegem, Ghent, Hasselt, Leuven, Ostend
2022-10-11
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bonheiden, Bruges, Brussels, Ghent, Leuven, Liège, Sint-Niklaas
2022-09-19
Active, closed
The Belgian Endothelial Surgical Transplant of the Cornea
NCT05436665Corneal Edema, Corneal Endothelial Disorder, Fuchs' Endothelial Dystrophy, Bullous Keratopathy
University Hospital, Antwerp
Not applicable
220
Edegem, Ghent, Bruges, Bonheiden, Brussels, Deurne, Genk, Leuven
2022-08-10
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Bonheiden, Brussels, La Louvière, Libramont, Yvoir, Aalst, Ghent, Kortrijk
2022-08-08
Recruiting
Research Maatschap Cardiologen Rotterdam Zuid
Phase 4
1,656
Bonheiden, Bruges, Genk, Leuven, Roeselare
2022-07-22
Active, closed
Pfizer
Phase 2
108
Bonheiden, Anderlecht, Brussels
2022-07-11
Recruiting
Belgian Group of Digestive Oncology
Phase 2
134
Antwerp, Brussels, Liège, Bruges, Bonheiden, Charleroi, Ghent, Haine-Saint-Paul
2022-05-25
Recruiting
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
NCT05246813Osteoporosis, Osteoarthritis, Hip, Hip Fractures, Clonal Hematopoiesis of Indeterminate Potential
Imelda Hospital, Bonheiden
Observational
24
Bonheiden
2022-02-11
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bonheiden, Brussels, Ghent, Leuven, Liège
2021-12-02
Recruiting
National University of Ireland, Galway, Ireland
Not applicable
2,540
Aalst, Bonheiden, Charleroi, Hasselt
2021-11-12
Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216Acute Stroke, Ischemic Stroke, Stroke
DiaMedica Therapeutics Inc
Phase 2/3
728
Bonheiden, Ghent, Hasselt, Kortrijk, Ottignies, Liège
2021-11-07
Active, closed
Eli Lilly and Company
Phase 3
874
Bonheiden, Brussels, Ghent, Sint-Niklaas, Leuven, Kortrijk, Namur
2021-10-04
Active, closed
Dafne Balemans
Phase 4
736
Antwerp, Bonheiden, Brasschaat, Bruges, Brussels, Genk, Ghent, Lennik
2021-05-25
Active, closed
Alfasigma S.p.A.
Observational
1,304
Aalst, Bonheiden, Bruges, Brussels, Charleroi, Edegem, Genk, Ghent
2021-05-11
Active, closed
PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS
NCT04730154Breast Neoplasms, Survivorship, Pain, Chronic
Universitair Ziekenhuis Brussel
Not applicable
156
Bornem, Jette, Diepenbeek, Bonheiden
2021-04-01
Recruiting
Imelda Hospital, Bonheiden
Not applicable
110
Bonheiden, Bruges, Leuven
2021-03-24
Active, closed
BioNTech SE
Phase 2
327
Bonheiden, Brasschaat, Charleroi, Kortrijk, La Louvière, Leuven, Roeselare, Wilrijk
2021-03-08
Active, closed
Dominque Bullens
Not applicable
62
Leuven, Bonheiden, Bruges, Ghent
2020-12-09
Active, closed
Exelixis
Phase 3
575
Bonheiden, Ghent, Brussels, Roeselare
2020-10-19
Active, closed
Eli Lilly and Company
Phase 3
996
Bonheiden, Brussels, Ghent, Leuven
2020-06-22
Active, closed
ANEUFIX for Endoleak Type II Repair
NCT03918460Abdominal Aortic Aneurysm, Endoleak
TripleMed B.V.
Not applicable
40
Bonheiden, Genk, Leuven
2020-05-13
Active, closed
KANDO Research
Not applicable
286
Aalst, Bonheiden, Dendermonde, Genk, Kortrijk, Mechelen, Vilvoorde
2020-05-05
Active, closed
Universitaire Ziekenhuizen KU Leuven
Observational
1,600
Leuven, Aalst, Antwerp, Arlon, Bonheiden, Bruges, Brussels, Charleroi
2020-03-12
Active, closed
Ipsen
Observational
150
Aalst, Bonheiden, Bouge, Bruges, Brussels, Genk, Ghent, La Louvière
2020-03-03
Active, closed
KANDO Research
Not applicable
302
Antwerp, Aalst, Bonheiden, Dendermonde, Genk, Tienen
2020-02-18
Recruiting
Diagram B.V.
Not applicable
500
Bonheiden, Bruges
2020-02-03
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Bonheiden, Brussels
2019-12-17
Active, closed
Bristol-Myers Squibb
Phase 3
839
Bonheiden, Anderlecht, Leuven
2019-08-05
Active, closed
9-ING-41 in Patients With Advanced Cancers
NCT03678883Cancer, Pancreatic Cancer, Sarcoma, Renal Cancer
DrugsCCNU·Lomustine·Abraxane·Adriamycin
Actuate Therapeutics Inc.
Phase 2
350
Edegem, Bonheiden, Ghent, Leuven
2019-01-04
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,240
Bonheiden, Edegem, Anderlecht, Brussels, Liège, Hasselt, Yvoir, Ghent
2018-12-27
Active, closed
Memic Innovative Surgery
Not applicable
50
Bonheiden
2018-11-08
Active, closed
AbbVie
Phase 3
1,242
Bonheiden, Anderlecht, Brussels, Liège, Yvoir, Leuven, Roeselare
2018-08-28
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Bonheiden, Brussels, Liège
2018-05-14
Active, closed
AbbVie
Phase 3
1,336
Bonheiden, Mechelen, Merksem, Anderlecht, Brussels, Liège, Yvoir, Ghent
2018-04-09
Active, closed
Eisai Inc.
Phase 3
1,069
Aalst, Antwerp, Bonheiden, Brussels, Hasselt, Liège, Wilrijk
2016-10-13
Active, closed
Tesaro, Inc.
Phase 3
733
Bonheiden, Brussels, Ghent, Hasselt, Leuven, Libramont, Namur
2016-07-11
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Aalst, Antwerp, Bonheiden, Brussels, Haine Saint Paul La Louviere, Leuven, Liège, Namur
2015-11-19
Recruiting
The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders
NCT07021404Suicidal Ideation, Suicide Attempt, Multicenter Study, Epidemiological Study
University Hospital, Ghent
Observational
50,000
Aalst, Antwerp, Bilzen, Bonheiden, Brasschaat, Bruges, Deinze, Dendermonde
2006-12-31
Rows per page Showing 1–101 of 101
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Belgian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-belgium/city/bonheiden

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Belgium and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,055 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 101 of those studies with a site in Bonheiden.

How many clinical trials are recruiting in Bonheiden?

52 of the 101 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 44 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bonheiden), 101 studies
PhaseStudiesRecruitingShare
Phase 3371436.6%
Observational221321.8%
Not applicable201119.8%
Phase 21049.9%
Phase 4655.9%
Phase 2/3545%
Phase 1/2111%

Most active sponsors

Lead sponsors with the most studies (Bonheiden)
Lead sponsorStudiesRecruiting
Universitaire Ziekenhuizen KU Leuven97
AbbVie84
Eli Lilly and Company83
Bristol-Myers Squibb31
Janssen Research & Development, LLC31
KANDO Research31
Novo Nordisk A/S31
Alfasigma S.p.A.20
Alimentiv Inc.22
AstraZeneca21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.